Application of Artificial Intelligence in the Diagnosis and Treatment of COVID-19 Lung Disease

Jalaeian Zaferani, Teshnehlab, Nadji
{"title":"Application of Artificial Intelligence in the Diagnosis and Treatment of COVID-19 Lung Disease","authors":"Jalaeian Zaferani, Teshnehlab, Nadji","doi":"10.31038/jipc.2021122","DOIUrl":null,"url":null,"abstract":"COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Perspectives on COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31038/jipc.2021122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能在COVID-19肺部疾病诊治中的应用
2019年,新型冠状病毒病从中国武汉开始在全球传播,原因不明[1,2]。这种疾病是由SARS-CoV-2病毒引起的,在短时间内感染了世界各地的许多人。据全球统计,目前约有2.55亿人感染该病,512万人死于该病[3]。紧急情况促使卫生专业人员和卫生中心制定指导方针,以防止疾病链的传播并对患者进行治疗。常见的症状包括发烧、咳嗽、疲劳、嗅觉或味觉丧失。此外,患者可能会出现喉咙痛、头痛、眼睛发炎和腹泻。更严重的病例可能包括胸痛和呼吸短促,患者应立即去看医生和医院[4]。自出现以来,该病毒已出现突变,导致疾病传播和严重程度增加,最终导致死亡率增加。一些明显的变异是Alpha, Beta, Gamma和Delta物种,其中Delta突变变得更加强烈。虽然普遍接种疫苗的过程使人类对该病毒的抵抗力增强,但该疾病现在正在导致伤害和死亡[5]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Anergy in COVID-19 Infected and COVID-19 vaccinee A Novel Strategy for Communication to Drive Voluntary Compliance with Social Distancing in COVID-19 across Religious-Cultures in Mumbai India – The Case of ‘Cognitive Polyphasia’ Application of Artificial Intelligence in the Diagnosis and Treatment of COVID-19 Lung Disease Analysis of the New Prescriptions Created in Our Organization during the First Twelve Months after the Declaration of the State of Alarm Due to SARS-CoV-2 Driving to Comply: Mind Genomics, Arizona, and the COVID-19 Vaccine
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1